Invasive Candida infections in solid organ transplant recipient children

References

• Fonseca-Aten M, Michaels G. Infections in pediatric solid organ transplant recipients. Semin. Pediatr. Surg.15, 153–161 (2006).
   PubMedGoogle Scholar
• Michaels MG, Michael G. Infections in pediatric transplant recipients: not just small adults. Infect. Dis. Clin. N. Am.24, 307–318 (2010).
   PubMedGoogle Scholar
• Keough WL, Michaels MG. Infectious complications in pediatric solid organ transplantation. Pediatr. Clin. N. Am.50, 1451–1469 (2003).
   PubMedGoogle Scholar
• Sims CR, Ostrosky-Zeichner L, Rex JH. Invasive candidiasis in immunocompromised hospitalized patients. Arch. Med. Res.36, 660–671 (2005).
   PubMed Web of Science ®Google Scholar
• Allen U, Green M. Prevention and treatment of infectious complications after solid organ transplantation in children. Pediatr. Clin. N. Am.57, 459–479 (2010).
   PubMedGoogle Scholar
• Singh N. Fungal infections in the recipients of solid organ transplantation. Infect. Dis. Clin. N. Am.17, 113–134 (2003).
   PubMed Web of Science ®Google Scholar
• van Hall SJ, Marriot DJE, Chen SCA et al. Candidemia following solid organ transplantation in the era of antifungal prophylaxis: the Australian experience. Transpl. Infect. Dis.11, 122–127 (2009).
   PubMedGoogle Scholar
• Grossi PA. Clinical aspects of invasive candidiasis in solid organ transplant recipients. Drugs69(Suppl. 1), 15–20 (2009).
   PubMedGoogle Scholar
• Pappas PG, Silveira FP; AST Infectious Diseases Community of Practice. Candida in solid organ transplant recipients. Am. J. Transplant9(Suppl. 4), S173–S179 (2009).
   PubMed Web of Science ®Google Scholar
• Neofytos D, Fishman JA, Horn D et al. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients. Transpl. Infect. Dis.12, 220–229 (2010).
   PubMed Web of Science ®Google Scholar
• Pappas PG, Alexander BD, Andes DR et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin. Infect. Dis.50, 1101–1111 (2010).
   PubMed Web of Science ®Google Scholar
• Person AK, Kontoyiannis DP, Alexander BD. Fungal infections in transplant and oncology patients. Infect. Dis. Clin. North Am.24, 439–459 (2010).
   PubMed Web of Science ®Google Scholar
• Pugliese F, Ruberto F, Cappannoli A et al. Incidence of fungal infections in a solid organ recipients dedicated intensive care unit. Transplant. Proc.39, 2005–2007 (2007).
   PubMedGoogle Scholar
• Silveira FP, Husain S. Fungal infections in solid organ transplantation. Med. Mycol.45, 305–320 (2007).
   PubMed Web of Science ®Google Scholar
• Pappas PG, Andes D, Schuster M et al. Invasive fungal infections in low-risk liver transplant recipients: a multi-center prospective observational study. Am. J. Transplant.6, 386–391 (2006).
   PubMed Web of Science ®Google Scholar
• Singh N. Antifungal prophylaxis for solid organ transplant recipients: seeking clarity amidst controversy. Clin. Infect. Dis.31, 545–553 (2000).
   PubMed Web of Science ®Google Scholar
• Schaenman JM, Rosso F, Austin JM et al. Trends in invasive disease due to Candida species following heart and lung transplantation. Transpl. Infect. Dis.11, 112–121 (2009).
   PubMed Web of Science ®Google Scholar
• Shao-hua S, An-wei L, Yan S et al. Spectrum and risk factors for invasive candidiasis and non-Candida fungal infections after liver transplantation. Chin. Med. J.121, 625–630 (2008).
   PubMedGoogle Scholar
• Husain S, Tollemar J, Dominguez EA et al. Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study. Transplantation75, 2023–2029 (2003).
   PubMed Web of Science ®Google Scholar
• Verma A, Wade JJ, Cheeseman P et al. Risk factors for fungal infection in paediatric liver transplant recipients. Pediatr. Transplant.9, 220–225 (2005).
   PubMedGoogle Scholar
• Green MD, Michaels MG. Opportunistic infections in liver and intestinal transplantation. In: Textbook of Pediatric Infectious Diseases (6th Edition). Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL (Eds). Saunders Elsevier, PA, USA, 1082–1095 (2009).
   Google Scholar
• Hauser GJ, Kaufman SS, Matsumoto CS, Fishbein TM. Pediatric intestinal and multivisceral transplantation: a new challenge for the pediatric intensivist. Intensive Care Med.34, 1570–1579 (2008).
   PubMedGoogle Scholar
• Avitzur Y, Grant D. Intestine transplantation in children: update 2010. Pediatr. Clin. N. Am.57, 415–431 (2010).
   PubMedGoogle Scholar
• Solé A, Salavert M. Fungal infections after lung transplantation. Transplant Rev.22, 89–104 (2008).
   Google Scholar
• Hoffman JA. Infections in pediatric lung transplantation. In: Textbook of Pediatric Infectious Diseases (6th Edition). Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL (Eds). Saunders Elsevier, PA, USA, 1058–1082 (2009).
   Google Scholar
• Hosseini-Moghaddam SM, Husain S. Fungi and molds following lung transplantation. Semin. Respir. Crit. Care Med.31, 222–233 (2010).
   PubMedGoogle Scholar
• Danziger-Isakov LA, Worley S, Arrigain S et al. Increased mortality after pulmonary fungal infection within the first year after pediatric lung transplantation. J. Heart Lung Transplant.27, 655–661 (2008).
   PubMedGoogle Scholar
• Danziger-Isakov LA, Sweet S, Delamorena M, Huddleston CB, Mendeloff E, Debaun MR. Epidemiology of bloodstream infections in the first year after pediatric lung transplantation. Pediatr. Infect. Dis. J.24, 324–330 (2005).
   PubMed Web of Science ®Google Scholar
• Gambino A, Cerutti A, Feltrin G et al. Outcome after pediatric heart transplantation: two decades of a single center experience. Eur. J. Cardiothorac. Surg.32, 220–224 (2007).
   PubMedGoogle Scholar
• Groetzner J, Reichart B, Roemer U et al. Cardiac transplantation in pediatric patients: fifteen-years experience of a single center. Ann. Thorac. Surg.79, 53–61 (2005).
   PubMed Web of Science ®Google Scholar
• Kaplan SL. Infections in pediatric heart transplantation. In: Textbook of Pediatric Infectious Diseases (6th Edition). Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL (Eds). Saunders Elsevier, PA, USA, 1047–1058 (2009).
   Google Scholar
• Albano L, Bretagne S, Mamzer-Bruneel MF et al. French Mycosis Study Group. Evidence that graft-site Candidiasis after kidney transplantation is acquired during organ recovery: a multicenter study in France. Clin. Infect. Dis.48, 194–202 (2009).
   PubMed Web of Science ®Google Scholar
• Badiee P, Kordbacheh P, Alborzi A, Zeini F, Mirhendy H, Mahmoody M. Fungal infections in solid organ recipients. Exp. Clin. Transplant.3, 385–389 (2005).
   PubMedGoogle Scholar
• Moreno A, Cervera C, Gavalda J et al. Bloodstream infections among transplant recipients: results of a nationwide surveillance in Spain. Am. J. Transplant.7, 2579–2586 (2007).
   PubMed Web of Science ®Google Scholar
• van Hall SJ, Stark D, Harkness J, Marriot D. Candida dubliniensis meningitis as delayed sequela of treated C. dubliniensis fungemia. Emerg. Infect. Dis.14, 327–329 (2008).
   PubMedGoogle Scholar
• Mubareka S, Vinh DC, Sanche SE. Candida dubliniensis bloodstream infection: a fatal case in a lung transplant recipient. Transplant. Infect. Dis.7, 146–149 (2005).
   PubMed Web of Science ®Google Scholar
• Laouad I, Buchler M, Noel C et al. Renal artery aneurysm secondary to Candida albicans in four kidney allograft recipients. Transplant. Proc.37, 2834–2836 (2005).
   PubMed Web of Science ®Google Scholar
• Mai H, Champion L, Ouali N et al. Candida albicans arteritis transmitted by conservative liquid after renal transplantation: a report of four cases and review of the literature. Transplantation82, 1163–1167 (2006).
   PubMedGoogle Scholar
• Rossetto A, Baccarani U, Lorenzin D et al. Disseminate fungal infection after acute pancreatitis in a simultaneous pancreas-kidney recipient. J. Transplant. DOI: 10.1155/2010/898245 (2010) (Epub ahead of print).
   PubMedGoogle Scholar
• Dictar MO, Maiolo E, Alexander B, Jacob N, Veron MT. Mycosis in the transplanted patient. Med. Mycol.38(Suppl. 1), 251–258 (2000).
   PubMed Web of Science ®Google Scholar
• Costa SF, Alexander BD. Non-Aspergillus fungal pneumonia in transplant recipients. Clin. Chest Med.26, 675–690 (2005).
   PubMedGoogle Scholar
• Knapp KM, Flynn PM. Candidiasis. In: Textbook of Pediatric Infectious Diseases (6th Edition). Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL (Eds). Saunders Elsevier, PA, USA, 2741–2751 (2009).
   Google Scholar
• Peman J, Zaragoza R. Current diagnostic approaches to invasive candidiasis in critical care settings. Mycosis53(5), 424–433 (2010).
   PubMed Web of Science ®Google Scholar
• Montagna MT, Caggiano G, Borghi E, Morace G. The role of the laboratory in the diagnosis of invasive candidiasis. Drugs69(Suppl. 1), 59–63 (2009).
   PubMedGoogle Scholar
• Laín A, Elguezabal N, Amutio E, Fernández de Larrinoa I, Moragues MD, Pontón J. Use of recombinant antigens for the diagnosis of invasive candidiasis. Clin. Dev. Immunol.2008, 721950 (2008).
   PubMedGoogle Scholar
• Chen SC, Kontoyiannis DP. New molecular and surrogate biomarker-based tests in the diagnosis of bacterial and fungal infection in febrile neutropenic patients. Curr. Opin. Infect. Dis.23, 567–577 (2010).
   PubMed Web of Science ®Google Scholar
• Ostrosky-Zeichner L, Alexander BD, Kett DH et al. Multicenter clinical evaluation of the 1→3-β-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin. Infect. Dis.41, 654–659 (2005).
   PubMed Web of Science ®Google Scholar
• Senn L, Robinson JO, Schmidt S et al. 1,3-β-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin. Infect. Dis.46, 878–885 (2008).
   PubMed Web of Science ®Google Scholar
• De Pauw B, Walsh TJ, Donnelly JP et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin. Infect. Dis.46, 1813–1821 (2008).
   PubMed Web of Science ®Google Scholar
• Pappas PG. Opportunistic fungi: a view to the future. Am. J. Med. Sci.340, 253–257 (2010).
   PubMed Web of Science ®Google Scholar
• Alexander BD, Smith PB, Davis RD, Perfect JR, Reller LB. The (1,3) β-D-glucan test as an aid to early diagnosis of invasive fungal infections following lung transplantation. J. Clin. Microbiol.4083–4088 (2010).
   PubMedGoogle Scholar
• Ellis M, Al-Ramadi B, Bernsen R, Kristensen J, Alizadeh H, Hedstrom U. Prospective evaluation of mannan and anti-mannan antibodies for diagnosis of invasive Candida infections in patients with neutropenic fever. J. Med. Microbiol.58, 606–615 (2009).
   PubMed Web of Science ®Google Scholar
• Lass-Flörl C. Invasive fungal infections in pediatric patients: a review focusing on antifungal therapy. Expert Rev. Anti Infect. Ther.8, 127–135 (2010).
   PubMed Web of Science ®Google Scholar
• Khot PD, Fredricks DN. PCR-based diagnosis of human fungal infections. Expert Rev. Anti Infect. Ther.7, 1201–1221 (2009).
   PubMed Web of Science ®Google Scholar
• Paya CV. Prevention of fungal infection in transplantation. Transpl. Infect. Dis.4, 46–51 (2002).
   PubMedGoogle Scholar
• Playford EG, Webster AC, Craig JC, Sorrell TC. Antifungal agents for preventing fungal infections in solid organ transplant recipients. Cochrane. Database System. Rev. (3), CD004291 (2004).
   Google Scholar
• Cruciani M, Mengoli C, Malena M, Bosco O, Serpelloni G, Grossi P. Antifungal prophylaxis in liver transplant patients: a systematic review and meta-analysis. Liver Tranpl.12, 850–858 (2006).
   PubMed Web of Science ®Google Scholar
• Playford EG, Webster AC, Sorrell TC, Craig JC. Systematic review and meta-analysis of antifungal agents for preventing fungal infections in liver transplant recipients. Eur. J. Clin. Microbiol. Infect. Dis.25, 549–561 (2006).
   PubMedGoogle Scholar
• Fortun J, Martin-Davila P, Montejo M et al. Prophylaxis with caspofungin for invasive fungal infections in high-risk liver transplant recipients. Transplantation87, 424–435 (2009).
   PubMed Web of Science ®Google Scholar
• Salavert M. Prophylaxis, pre-emptive or empirical antifungal therapy: which is best in non-lung transplant recipients?. Inter. J. Antimicrob. Agents32, 149–153 (2008).
   PubMedGoogle Scholar
• Pappas PG, Kauffman CA, Andes D et al. Clinical practice guidelines for the management of candidiasis: 2009 update by Infectious Diseases Society of America. Clin. Infect. Dis.48, 503–535 (2009).
   PubMed Web of Science ®Google Scholar
• Andreas HG, Walsh TJ. Antifungal agents. In: Textbook of Pediatric Infectious Diseases (6th Edition). Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL (Eds). Saunders Elsevier, PA, USA, 3271–3308 (2009).
   Google Scholar
• Arendrup MC, Fisher BT, Zaoutis TE. Invasive fungal infections in the paediatric and neonatal population: diagnostics and management issues. Clin. Microbiol. Infect.15, 613–624 (2009).
   PubMed Web of Science ®Google Scholar
• Lipp HP. Antifungal agents-clinical pharmacokinetics and drug interactions. Mycoses51, 7–18 (2008).
   PubMedGoogle Scholar
• Singh N. Antifungal prophylaxis in solid-organ transplant recipients: considerations for clinical trial design. Clin. Infect. Dis.39, S200–S206 (2004).
   Google Scholar
• Petrovic J, Ngai A, Bradshaw S et al. Efficacy and safety of caspofungin in solid organ transplant recipients. Transplant Proc.39, 3117–3120 (2007).
   PubMedGoogle Scholar
• Winkler M, Pratschke J, Schulz U et al. Caspofungin for solid organ transplant invasive fungal disease: results of a retrospective observational study. Transpl. Infect. Dis.12, 230–237 (2010).
   PubMedGoogle Scholar
• Fisher BT, Zaoutis TT. Caspofungin for the treatment of pediatric fungal infections. Pediatr. Infect. Dis. J.27, 1099–1102 (2008).
   PubMedGoogle Scholar
• Lehrnbecher T, Groll AH. Micafungin: a brief of pharmacology, safety, and antifungal efficacy in pediatric patients. Pediatr. Blood Cancer55, 229–232 (2010).
   PubMed Web of Science ®Google Scholar
• Benjamin DK Jr, Driscoll T, Seibel NL et al. Safety and pharmacokinetics of intravenous anidulafungin in children with neutropenia at high risk for invasive fungal infections. Antimicrob. Agents Chemother.50, 632–638 (2009).
   Web of Science ®Google Scholar
• Demmler-Harrison GJ. Opportunistic infections in kidney transplantation. In: Textbook of Pediatric Infectious Diseases (6th Edition). Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL (Eds). Saunders Elsevier, PA, USA, 1095–1108 (2009).
   Google Scholar